TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation.

management outcome surgery transcatheter intervention tricuspid regurgitation

Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
25 Aug 2023
Historique:
received: 04 08 2023
revised: 15 08 2023
accepted: 24 08 2023
medline: 25 8 2023
pubmed: 25 8 2023
entrez: 25 8 2023
Statut: aheadofprint

Résumé

Benefit of tricuspid regurgitation (TR) correction and timing of intervention are unclear. This study aimed to compare survival rates after surgical or transcatheter intervention to conservative management according to TR clinical stage as assessed using the TRI-SCORE. 2,413 patients with severe isolated functional TR were enrolled in TRIGISTRY (1217 conservatively managed, 551 isolated tricuspid valve surgery and 645 transcatheter valve repair). The primary endpoint was survival at 2 years. The TRI-SCORE was low (≤3) in 32%, intermediate (4-5) in 33% and high (≥6) in 35%. A successful correction was achieved in 97% and 65% of patients in the surgical and transcatheter groups, respectively. Survival rates decreased with the TRI-SCORE in the three treatment groups (all P < 0.0001). In the low TRI-SCORE category, survival rates were higher in the surgical and transcatheter groups than in the conservative management group (93%, 87% and 79%, respectively; P = 0.0002). In the intermediate category, no significant difference between groups was observed overall (80%, 71% and 71%, respectively; P = 0.13) but benefit of the intervention became significant when the analysis was restricted to patients with successful correction (80%, 81% and 71%, respectively; P = 0.009). In the high TRI-SCORE category, survival was similar between groups even when restricted to patients with successful correction (61%, 68% and 58% respectively, P = 0.08). Survival progressively decreased with the TRI-SCORE irrespective of treatment modality. Compared to conservative management, an early and successful surgical or transcatheter intervention improved 2-year survival in patients at low and, to a lower extent, intermediate TRI-SCORE, while no benefit was observed in the high TRI-SCORE category.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Benefit of tricuspid regurgitation (TR) correction and timing of intervention are unclear. This study aimed to compare survival rates after surgical or transcatheter intervention to conservative management according to TR clinical stage as assessed using the TRI-SCORE.
METHODS METHODS
2,413 patients with severe isolated functional TR were enrolled in TRIGISTRY (1217 conservatively managed, 551 isolated tricuspid valve surgery and 645 transcatheter valve repair). The primary endpoint was survival at 2 years.
RESULTS RESULTS
The TRI-SCORE was low (≤3) in 32%, intermediate (4-5) in 33% and high (≥6) in 35%. A successful correction was achieved in 97% and 65% of patients in the surgical and transcatheter groups, respectively. Survival rates decreased with the TRI-SCORE in the three treatment groups (all P < 0.0001). In the low TRI-SCORE category, survival rates were higher in the surgical and transcatheter groups than in the conservative management group (93%, 87% and 79%, respectively; P = 0.0002). In the intermediate category, no significant difference between groups was observed overall (80%, 71% and 71%, respectively; P = 0.13) but benefit of the intervention became significant when the analysis was restricted to patients with successful correction (80%, 81% and 71%, respectively; P = 0.009). In the high TRI-SCORE category, survival was similar between groups even when restricted to patients with successful correction (61%, 68% and 58% respectively, P = 0.08).
CONCLUSION CONCLUSIONS
Survival progressively decreased with the TRI-SCORE irrespective of treatment modality. Compared to conservative management, an early and successful surgical or transcatheter intervention improved 2-year survival in patients at low and, to a lower extent, intermediate TRI-SCORE, while no benefit was observed in the high TRI-SCORE category.

Identifiants

pubmed: 37624856
pii: 7250504
doi: 10.1093/eurheartj/ehad585
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Julien Dreyfus (J)

Department of Cardiology, Centre Cardiologique du Nord, Saint-Denis, France.

Xavier Galloo (X)

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
Department of Cardiology, Free University Brussels (VUB), University Hospital Brussels (UZ Brussel), Brussels, Belgium.

Maurizio Taramasso (M)

HerzZentrum Hirslanden Zürich, Switzerland.

Gregor Heitzinger (G)

Department for Internal Medicine II, Cardiology, Medical University of Vienna, Vienna, Austria.

Giovanni Benfari (G)

Cardiovascular disease Department, Mayo Clinic, Rochester, MM, USA.
Section of Cardiology, Department of Medicine, University of Verona, Italy.

Karl-Patrick Kresoja (KP)

Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

Fernando Juarez-Casso (F)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MM, USA.

Hazem Omran (H)

General and Interventional Cardiology, Heart & Diabetes Center NRW, University Hospital of the Ruhr University Bochum, Bad Oeynhausen, Germany.

Yohann Bohbot (Y)

Department of Cardiology, Amiens University Hospital, Amiens, France.
UR UPJV 7517, Jules Verne University of Picardie, Amiens, France.

Christos Iliadis (C)

Department for Internal Medicine III, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Giulio Russo (G)

Policlinico Tor Vergata, University of Rome, Rome, Italy.

Yan Topilsky (Y)

Department of Cardiology, Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel Aviv, Israel.

Marcel Weber (M)

Heart Center University Hospital, Bonn, Germany.

Luis Nombela-Franco (L)

Interventional Cardiology, Hospital Clínico San Carlos, Madrid, Spain.

Alessandra Sala (A)

Vita-Salute San Raffaele University, Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Milan, Italy.

Andrea Eixerés-Esteve (A)

Cardiac Surgery Department, Hospital 12 de Octubre, Madrid, Spain.

Bernard Iung (B)

Cardiology Department, Bichat Hospital, APHP, and INSERM LVTS U1148, Université de Paris, Paris, France.

Jean-François Obadia (JF)

Department of Cardiovascular Surgery and Transplantation, Louis Pradel Cardiovascular Hospital, Claude Bernard University, Bron, France.

Rodrigo Estevez Loureiro (R)

Interventional Cardiology Clinic, University Hospital Alvaro Cunqueiro, Vigo, Spain.

Elisabeth Riant (E)

Department of Cardiology, Centre Cardiologique du Nord, Saint-Denis, France.

Erwan Donal (E)

Cardiology Department, LTSI UMR1099, INSERM, Université de Rennes-1, CHU de RENNES, Rennes, France.

Jörg Hausleiter (J)

Medical Clinic and Polyclinic I, University Hospital of Munich, Munich, Germany.

Luigi Badano (L)

Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Thierry Le Tourneau (T)

CNRS, INSERM, l'institut du thorax, Université de Nantes, CHU de Nantes, Nantes, France.

Augustin Coisne (A)

Department of Clinical Physiology and Echocardiography - Heart Valve Clinic, CHU Lille, Lille, France.
Institut Pasteur de Lille, U1011- EGID, Univ. Lille, Inserm, CHU Lille, Lille, France.

Thomas Modine (T)

Department of Cardiology and Cardio-Vascular Surgery, Hôpital Cardiologique de Haut-Leveque, Bordeaux University Hospital, Bordeaux, France.

Azeem Latib (A)

Division of Cardiology, Montefiore Medical Center.

Fabien Praz (F)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Stephan Windecker (S)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Jose Luis Zamorano (JL)

Department of Cardiology, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Ralph Stephan von Bardeleben (RS)

Division of Cardiology, University Medical Center, Mainz, Germany.

Gilbert H L Tang (GHL)

Department of Cardiovascular Surgery, Mount Sinai Health System, New York, NY, USA.

Rebecca Hahn (R)

Cardiology Department, NewYork-Presbyterian/Columbia University Medical Center, New York, NY, USA.

John Webb (J)

St. Paul Hospital, Vancouver, British Columbia, Canada.

Denisa Muraru (D)

Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Mohammed Nejjari (M)

Department of Cardiology, Centre Cardiologique du Nord, Saint-Denis, France.

Vincent Chan (V)

Department of Cardiac surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Michele De Bonis (M)

Vita-Salute San Raffaele University, Department of Cardiac Surgery, IRCCS San Raffaele Hospital, Milan, Italy.

Manuel Carnero-Alcazar (M)

Department of Cardiac Surgery, Hospital Clínico San Carlos, Madrid, Spain.

Georg Nickenig (G)

Heart Center University Hospital, Bonn, Germany.

Roman Pfister (R)

Department for Internal Medicine III, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Christophe Tribouilloy (C)

Department of Cardiology, Amiens University Hospital, Amiens, France.
UR UPJV 7517, Jules Verne University of Picardie, Amiens, France.

Volker Rudolph (V)

General and Interventional Cardiology, Heart & Diabetes Center NRW, University Hospital of the Ruhr University Bochum, Bad Oeynhausen, Germany.

Juan Crestanello (J)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MM, USA.

Philipp Lurz (P)

Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

Philipp Bartko (P)

Department for Internal Medicine II, Cardiology, Medical University of Vienna, Vienna, Austria.

Francesco Maisano (F)

Cardiac Surgery and Heart Valve Center, Ospedale San Raffaele, University Vita Salute, Milano, Italy.

Jeroen Bax (J)

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

Maurice Enriquez-Sarano (M)

Minneapolis Heart Institute, Minneapolis, Minnesota, USA.

David Messika-Zeitoun (D)

Department of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada.

Classifications MeSH